By Ellen Gabler, Chicago Tribune reporterNovember 13, 2011
Trainees were then taken to a separate room where the door was closed, and an experienced Abbott sales rep said to ignore corporate trainers' directions and instead market Depakote, an epilepsy drug, as a way to treat agitation associated with dementia, a practice that would be illegal, Thomas Spetter alleges in a whistle-blower lawsuit filed in 2010.
No comments:
Post a Comment